Obviously word leaked out on the failed rheumatoid arthritis trial CV-19 by REGN and Sanofi are the best in the biotech business if they cant get a phase 3 trial passed and over the finish line RVVTF rheumatoid arthritis isn't either sorry you can be realistic or not.
less than 275k cash lots of diluting going on here toxic financing.